Role of the alarmone (p)ppGpp in phenotypic antibiotic tolerance
警报酮 (p)ppGpp 在表型抗生素耐受性中的作用
基本信息
- 批准号:10302437
- 负责人:
- 金额:$ 24.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-17 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:Antibiotic ResistanceAntibiotic TherapyAntibioticsBacillus subtilisBacteriaBacterial InfectionsCell FractionCell SeparationCell WallCellsCharacteristicsDNA Sequence AlterationDNA biosynthesisDiseaseEnzymesExhibitsFailureFrequenciesGenetic TranscriptionGoalsGrowthHydrolaseIndividualInterventionKnowledgeLeadMetabolicMetabolismMethodsMutationNucleotidesNutrientOrganismPhasePhenotypePhysiologicalPhysiological ProcessesPhysiologyPlayPopulationProcessProtein BiosynthesisProteinsPublic HealthRecurrenceReporterResistanceRoleSecond Messenger SystemsSourceTranslationsTreatment FailureVariantWorkantibiotic tolerancebaseexperimental studyinsightnovelpathogenic bacteriapreventrecurrent infectionresponse
项目摘要
Project Summary
The emergence of pathogenic bacteria resistant to antibiotics is an urgent public health issue.
Resistance typically results from a specific genetic mutation that permanently alters the organism’s
sensitivity to a particular antibiotic. However, antibiotic sensitivity can also change transiently as
the result of phenotypic antibiotic tolerance, a phenomenon that is thought to underly treatment
failures in the case of recurrent bacterial infections. Antibiotic tolerance results from the entry of
bacteria into a transient growth-arrested and quiescent state where they are less sensitive to
compounds that inhibit processes such as DNA replication or cell wall synthesis and thus can
escape killing by antibiotics to which they are normally sensitive. While quiescence is
characteristic of most cells in a stationary phase culture, only a small fraction of the cells in a
exponentially growing culture are transiently quiescent. It is these cells – “persisters” - that are
thought to be responsible for the failure of antibiotic treatment in recurrent infections. How does
quiescence occur in only a sub-population? One proposed mechanism involves the nucleotide
second messengers (p)ppGpp that inhibit a broad range of physiological processes including
transcription and DNA replication leading to growth arrest and quiescence. It has been proposed
that variability in the amount of (p)ppGpp in cells could lead to variations in growth state and
thereby antibiotic sensitivity. We recently found that ~1% of an exponentially growing population
of Bacillus subtilis expresses substantially higher amounts of a (p)ppGpp synthase. The cells in
this sub-population exhibit increased antibiotic tolerance as compared to most cells in the
population that do not express this protein. In an important extension of this work, we have
developed a fluorescent reporter can be used to identify individual cells with elevated levels of
(p)ppGpp. We call these cells (p)ppGpphigh and they can be isolated by Fluorescent Activated Cell
Sorting (FACS). We propose to investigate (p)ppGpphigh cells in the following Aims. Aim 1 is to
characterize the (p)ppGpphigh cells and compare their physiological characteristics including
protein synthesis and DNA replication to average cells of the population. Aim 2 is to investigate
the cellular mechanisms responsible for the synthesis and degradation of (p)ppGpp in the
(p)ppGpphigh cells. The knowledge gained during the course of this project will deepen our
understanding of the physiology of persister bacteria and facilitate the identification of metabolic
vulnerabilities that could serve as potential targets for anti-persister strategies.
项目摘要
对抗生素产生耐药性的病原菌的出现是一个紧迫的公共卫生问题。
抗药性通常是由一种特定的基因突变引起的,这种突变永久地改变了有机体的
对一种特定抗生素的敏感性。然而,抗生素敏感性也可能发生短暂的变化,如
表型抗生素耐药的结果,一种被认为治疗不足的现象
在反复细菌感染的情况下失败。抗生素耐药是由于进入
细菌进入一种短暂的生长停滞和静止状态,在这种状态下它们对
抑制DNA复制或细胞壁合成等过程的化合物,因此可以
避免被抗生素杀死,而抗生素通常是敏感的。而静止则是
大多数细胞处于静止期培养的特点,只有一小部分细胞在
呈指数级增长的文化暂时停滞不前。正是这些细胞--“持久者”--
被认为是反复感染时抗生素治疗失败的原因。何以
静止期只出现在亚群中吗?一种被提出的机制涉及核苷酸
第二信使(P)ppGpp抑制广泛的生理过程,包括
转录和DNA复制导致生长停滞和停滞。已经有人提议
细胞中(P)ppGpp含量的变化可能会导致生长状态和
因此对抗生素的敏感性。我们最近发现,在呈指数级增长的人口中,约1%的人
枯草芽孢杆菌表达大量的(P)ppGpp合成酶。中的单元格
与大多数细胞相比,这一亚群表现出更高的抗生素耐受性
不表达这种蛋白质的人群。在这项工作的一个重要扩展中,我们有
开发的一种荧光报告器可以用来识别单个细胞,这些细胞的水平升高
(P)ppGpp。我们称这些细胞为(P)ppGpphigh,它们可以通过荧光激活的细胞分离出来
分类(FACS)。我们建议研究(P)ppGpphigh细胞以达到以下目的。目标1是
表征(P)ppGpphigh细胞并比较它们的生理特性,包括
蛋白质合成和DNA复制到群体的平均细胞。目标2是调查
(P)ppGpp合成和降解的细胞机制
(P)ppGpphigh细胞。在这个项目的过程中获得的知识将加深我们的
了解宿存细菌的生理学并促进代谢的鉴定
可能成为反持久策略的潜在目标的漏洞。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JONATHAN DWORKIN其他文献
JONATHAN DWORKIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JONATHAN DWORKIN', 18)}}的其他基金
Role of the alarmone (p)ppGpp in phenotypic antibiotic tolerance
警报酮 (p)ppGpp 在表型抗生素耐受性中的作用
- 批准号:
10406374 - 财政年份:2021
- 资助金额:
$ 24.3万 - 项目类别:
Regulation of protein synthesis during quiescence in bacteria
细菌静止期间蛋白质合成的调节
- 批准号:
10206408 - 财政年份:2021
- 资助金额:
$ 24.3万 - 项目类别:
Regulation of protein synthesis during quiescence in bacteria
细菌静止期间蛋白质合成的调节
- 批准号:
10553221 - 财政年份:2021
- 资助金额:
$ 24.3万 - 项目类别:
Regulation of protein synthesis during quiescence in bacteria
细菌静止期间蛋白质合成的调节
- 批准号:
10373068 - 财政年份:2021
- 资助金额:
$ 24.3万 - 项目类别:
Physiological responses to cell wall-active antibiotics in a Gram-positive bacterium
革兰氏阳性细菌对细胞壁活性抗生素的生理反应
- 批准号:
9434559 - 财政年份:2018
- 资助金额:
$ 24.3万 - 项目类别:
Regulation of Protein Synthesis in Bacteria by Ser/Thr Phosphorylation
Ser/Thr 磷酸化调节细菌蛋白质合成
- 批准号:
8862644 - 财政年份:2015
- 资助金额:
$ 24.3万 - 项目类别:
Regulation of Protein Synthesis in Bacteria by Ser/Thr Phosphorylation
Ser/Thr 磷酸化调节细菌蛋白质合成
- 批准号:
9264543 - 财政年份:2015
- 资助金额:
$ 24.3万 - 项目类别:
相似海外基金
SBIR Phase II: Development of a urine dipstick test that can guide immediate and appropriate antibiotic therapy for treatment of complicated urinary tract infections
SBIR II 期:开发尿液试纸测试,可以指导复杂尿路感染的立即和适当的抗生素治疗
- 批准号:
2213034 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
Cooperative Agreement
Personalized Antibiotic Therapy in the Emergency Department: PANTHER Trial
急诊科的个性化抗生素治疗:PANTHER 试验
- 批准号:
10645528 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
Strategies for improving the efficacy of combinatorial antibiotic therapy in chronic infections
提高慢性感染联合抗生素治疗疗效的策略
- 批准号:
10736285 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
A Novel Bone Targeted Antibiotic Therapy for the Treatment of Infected Fractures
一种治疗感染性骨折的新型骨靶向抗生素疗法
- 批准号:
10603486 - 财政年份:2023
- 资助金额:
$ 24.3万 - 项目类别:
Severe Cutaneous Adverse Reactions Following Outpatient Antibiotic Therapy: A Population-based Study
门诊抗生素治疗后的严重皮肤不良反应:一项基于人群的研究
- 批准号:
449379 - 财政年份:2020
- 资助金额:
$ 24.3万 - 项目类别:
Studentship Programs
Sex-Specific Differences in End-of-Life Burdensome Interventions and Antibiotic Therapy in Nursing Home Residents With Advanced Dementia
患有晚期痴呆症的疗养院居民的临终干预和抗生素治疗的性别差异
- 批准号:
422034 - 财政年份:2020
- 资助金额:
$ 24.3万 - 项目类别:
Optimizing outpatient parenteral antibiotic therapy to support hospital-in-the-home program across the unique environmental conditions of Australia
优化门诊肠外抗生素治疗,以支持澳大利亚独特环境条件下的家庭医院计划
- 批准号:
nhmrc : 1197866 - 财政年份:2020
- 资助金额:
$ 24.3万 - 项目类别:
Investigator Grants
Resistance evolution in the presence of combination antibiotic therapy
联合抗生素治疗下耐药性的演变
- 批准号:
2241853 - 财政年份:2019
- 资助金额:
$ 24.3万 - 项目类别:
Studentship
Host-pathogen interactions in antibiotic therapy for listeriosis
李斯特菌病抗生素治疗中宿主与病原体的相互作用
- 批准号:
18K07106 - 财政年份:2018
- 资助金额:
$ 24.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Multipurpose targeted nano-antibiotic therapy to fight tough infection in bones
多用途靶向纳米抗生素疗法可对抗骨骼中的严重感染
- 批准号:
9788269 - 财政年份:2018
- 资助金额:
$ 24.3万 - 项目类别: